Chemoinformaics analysis of (2R,6S,7S,10Z)-beta-Santala-3(15),10-dien-12-ol
Molecular Weight | 220.356 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 10 |
Exact Molecular Weight | 220.183 | nRing | 2 |
Solubility: LogS | -4.065 | nHRing | 0 |
Solubility: LogP | 2.848 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.716 |
Synth | 4.908 |
Natural Product Likeliness | 3.634 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.009 |
CACO-2 | -4.454 |
MDCK | 0.0000183 |
BBB | 0.974 |
PPB | 0.702434 |
VDSS | 1.401 |
FU | 0.209682 |
CYP1A2-inh | 0.104 |
CYP1A2-sub | 0.728 |
CYP2c19-inh | 0.071 |
CYP2c19-sub | 0.877 |
CYP2c9-inh | 0.046 |
CYP2c9-sub | 0.352 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.897 |
CYP3a4-inh | 0.171 |
CYP3a4-sub | 0.332 |
CL | 9.837 |
T12 | 0.556 |
hERG | 0.022 |
Ames | 0.011 |
ROA | 0.028 |
SkinSen | 0.47 |
Carcinogencity | 0.161 |
EI | 0.909 |
Respiratory | 0.892 |
NR-Aromatase | 0.165 |
Antiviral | Yes |
Prediction | 0.828429 |